Windhover Information’s 2nd Annual Therapeutic Area Partnerships is the industry’s most targeted and efficient partnering meeting for life science companies seeking partnerships in the top therapeutic areas: Oncology, Cardiovascular/Metabolic and Neuroscience. Decision-makers (business development and R & D) focusing on these therapeutic categories can meet to develop strategic alliances between their companies. Also, attendees enjoy the personal and interactive setting that combines company presentations, 1:1 meetings and networking functions.

Why attend TA Partnerships 2007? Use partnering software to pre-arrange and schedule partnership meetings that take place. PLUS:

• Capitalize on potential new business and collaboration opportunities with the hottest TA-focused companies
• Network with hundreds of potential pharmaceutical and biotech partners through 1:1 meetings, cocktail parties, luncheons and refreshment breaks
• Hear exciting new statistics, deal case studies and trends in therapeutic area partnering from an unbeatable line-up of senior level speakers
• Take back the most current conference and detailed information on delegates, their companies, projects and technologies
• Get pre-conference access to a database that includes detailed technical, non-confidential information on projects available for partnering (pre-clinical and clinical stage)

Benefit from Windhover’s carefully crafted Therapeutic-Specific sessions:

• Examining the Oncology/CV/Metabolic/Neuroscience marketplaces – where are the opportunities?
• Developing a commercial strategy
• Developing your value proposition in a highly competitive marketplace
• Drug reimbursement trends
• The most problematic and most exciting mechanisms under development

TA Partnerships 2007 is focused on the business of dealmaking, hosting partnering meetings all scheduled using our Industry-leading partnering software. Windhover hand-picks the presenting companies that grace our stage to ensure they represent the most exciting partnering candidates available, and a nice balance of opportunities across therapeutic categories, product types and geographies.

More Therapeutic Focus

Benefit from senior-level case studies from 4 therapeutic-specific tracks

• Track 1-Neuroscience
• Track 2-Cardiovascular
• Track 3-Metabolic
• Track 4-Oncology

More workshops (Included with your registration fees)

Take home practical insight on how to develop and commercialize your therapeutics through the following workshops :

Workshop 1

The Endless Challenge: Best Practices Demonstrating Safety and Proof of Concept In Clinical Development

Workshop 2

The New World of Commercialization and Reimbursement

Workshop 3

The Good, the Bad and the Ugly in Dealmaking

More content

1. Therapeutic Area Partnering – Predicting What Pharma Wants: Roger Longman on Therapeutic Alliances

• Which therapeutic areas attracts the most number of deals and alliance dollars
• Clinical development by indication – where are the clinical dollars going?

2. Large Pharma Panel with Merck, AstraZeneca and Bristol-Myers Squibb

• What is your interest level in the different TAs?
• Which TAs are attractive and why
• Are you open to going outside of stated TAs?

3. Top 10 Sessions – The Top 10 Most Licensable Projects in neuro, cardiovascular, metabolic and oncology, with each area analyst explaining the selection process and criteria and briefly describing the programs and companies chosen

Matchmaking in Drug Partnering: Identifying the Right Drugs and the Right Partners

Challenges in identifying good science

Market statistics and market potential

Competitive landscape

Where the most promising neuro drug programs are coming from

For a complete description of projects, click here.

4. Pharma’s New World Order: Mid-Size and Specialty Pharmaceuticals Take Center Stage

The panel will include three to four VP or C-level executives from midsize and large specialty pharma companie, and will cover:

Why Big Pharma isn’t always better pharma

Win-win alliances

How specialty differs from primary care deals

The impact of Big Pharma’s emerging interest in specialty products

Specialty and blockbuster are no longer contradictory terms; where to look for the next blockbuster specialty products

5. Poster sessions with the handpicked, Top 10 Most Licensable Projects in:

• Neuroscience
• Cardiovascular
• Metabolic
• Oncology

6. Challenges and Opportunities in Translating Advances into Prescribed Drugs with Some of the Industry’s Most Reputable R & D Leaders

• Challenges and opportunities in innovative discovery tools: what the industry needs
• How the industry is improving preclinical and toxicity predictors and human safety biomarkers
• Your view of the most problematic and most exciting mechanisms now under development

More Potential Partnering Opportunities

Schedule partnering meetings with global life science companies using Windhover’s proprietary partnering software

• Meet potential partners using software to pre-arrange and schedule several partnership meetings that take place at TA Partnerships
• Capitalize on potential new business and collaboration opportunities with the hottest global biotechs
• Take back the most current conference and detailed information on delegates, their companies, projects and technologies

Just a Sample of Past Attending Companies:

More Networking Opportunities

Network with hundreds of potential pharmaceutical and biotech partners through 1:1 meetings, 2 cocktail parties, 2 luncheons and 4 refreshment breaks

Benefit from Windhover Editorial’s first hand-case studies, best practices and lessons learned to help you build your own drug pipeline. Spaces are limited so Register Now for THE therapeutic specific meeting that brings you the latest cutting-edge compounds and partnering opportunities under one roof.

We look forward to greeting you in Philadelphia!